GRTX logo

Galera Therapeutics, Inc. (GRTX) Stock Analysis

DELISTED

What happened to Galera Therapeutics, Inc. (GRTX) stock?

Galera Therapeutics, Inc. (GRTX) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $3.56B| P/E Ratio: 0.06| Vol: 420| 52-wk range: $0.088 – $30.00

P/E 0.06 means the share price is 0.06 times one year of earnings per share. Market cap $3.56B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Galera Therapeutics, Inc. (GRTX). Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies to transform radiotherapy in cancer treatment. Their lead product candidate, avasopasem manganese (GC4419), targets radiotherapy-induced severe oral mucositis.

Last analyzed: May 8, 2026
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies to transform radiotherapy in cancer treatment. Their lead product candidate, avasopasem manganese (GC4419), targets radiotherapy-induced severe oral mucositis.

These figures come from statements filed 13 months ago — the most recent this company has published.

Galera Therapeutics, Inc. (GRTX) Healthcare & Pipeline Overview

Employees3
Model self-rating on this text: 66% (not a measure of the evidence) Updated: May 8, 2026

GRTX OTC Market Information

GRTX trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy GRTX shares?

No. GRTX stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for GRTX elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before GRTX stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Galera Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.